对BCR::ABL1抑制剂的内在细胞抵抗
Nataly Cruz-Rodriguez1, Yulieth Torres-Llanos1, Michael W Deininger1
1Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Ann Arbor, MI.
Haematologica
|February 12, 2026
概括
慢性髓性白血病 (CML) 用氨酸激酶抑制剂 (TKIs) 治疗改善了生存率,但耐药性仍然存在. 了解BCR::ABL1独立抗性机制对于开发新疗法至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 氨酸激酶抑制剂 (TKIs) 彻底改变了慢性髓性白血病 (CML) 的治疗方法,显著改善了患者的生存率.
- 尽管TKI取得了成功,但药物耐药性和持续的最小残留疾病等挑战仍然存在,需要进一步研究.
研究的目的:
- 审查CML中的细胞内在抵抗机制,包括BCR::ABL1激酶活性和BCR::ABL1独立途径.
- 探索CML如何逃避TKI效应,并提出BCR::ABL1功能超出酶活性之外的低估的作用.
主要方法:
- 在CML中细胞内在抵抗机制的文献综述.
- 对BCR::ABL1驱动的血造干细胞和祖细胞重编程的分析.
主要成果:
- 接受TKI治疗的患者的生存率接近正常,但耐药性和残留白血病仍然存在.
- BCR::ABL1独立的抵抗机制有助于TKI衰竭和疾病进展.
- 除了激酶活性之外的BCR::ABL1功能可能在CML病变发生过程中至关重要.
结论:
- 了解多样化的抵抗机制是克服CML中TKI限制的关键.
- 针对BCR::ABL1功能超越激酶活性,可能与降解剂一起,提供了一个有前途的治疗策略.
相关概念视频
Intrinsically Disordered Proteins
19.6K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.6K
Intrinsically Disordered Proteins
2.9K
2.9K
Eukaryotic Transcription Inhibitors
11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Extrinsic and Intrinsic Pathways of Hemostasis
13.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.2K
The Intrinsic Apoptotic Pathway
8.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.7K
Resistivity
4.6K
When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K


